{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.35B vs. cons $3.31B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$588M vs. cons $580M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.46 vs. cons $1.43",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 revenue",
      "prediction": "LOWER",
      "answer": "guide ~$13.00B midpoint vs. cons $13.05B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EBITDA",
      "prediction": "LOWER",
      "answer": "guide ~$2.42B midpoint vs. cons $2.43B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$5.90 midpoint vs. cons $5.95 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 free cash flow",
      "prediction": "LOWER",
      "answer": "guide ~$750M midpoint vs. cons $760M (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 2.4,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.6,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 adjusted EPS beat of ~$1.46 vs. $1.43 consensus should support the initial reaction, but FY2026 adjusted EPS guidance of ~$5.90 vs. $5.95 consensus leaves the out-period burden largely intact. With Q2 adjusted EBITDA of ~$588M vs. $580M consensus but FY2026 EBITDA guidance near ~$2.42B vs. $2.43B consensus, post-report revisions are likely flat to slightly negative, causing most of the day-1 gain to fade.",
  "day5_confidence": "MEDIUM"
}